Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $137,915 | 55 | 79.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,202 | 3 | 8.8% |
| Travel and Lodging | $13,679 | 30 | 7.9% |
| Food and Beverage | $2,877 | 41 | 1.7% |
| Honoraria | $2,500 | 1 | 1.4% |
| Grant | $350.00 | 1 | 0.2% |
| Education | $24.26 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $64,444 | 36 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $25,378 | 28 | $0 (2020) |
| Mylan Inc. | $18,400 | 17 | $0 (2019) |
| Genentech, Inc. | $15,642 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $7,910 | 4 | $0 (2024) |
| Gilead Sciences, Inc. | $5,964 | 9 | $0 (2022) |
| Eisai Co., Ltd. | $5,915 | 4 | $0 (2021) |
| Immunomedics, Inc. | $5,638 | 1 | $0 (2020) |
| Genentech USA, Inc. | $5,099 | 5 | $0 (2019) |
| PFIZER INC. | $4,421 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,967 | 7 | Daiichi Sankyo Inc. ($7,535) |
| 2023 | $7,021 | 5 | Daiichi Sankyo Inc. ($5,309) |
| 2022 | $26,153 | 19 | Daiichi Sankyo Inc. ($16,283) |
| 2021 | $16,951 | 11 | Daiichi Sankyo Inc. ($10,480) |
| 2020 | $18,558 | 9 | Daiichi Sankyo Inc. ($6,470) |
| 2019 | $47,917 | 32 | Mylan Inc. ($15,288) |
| 2018 | $37,800 | 42 | Merck Sharp & Dohme Corporation ($13,899) |
| 2017 | $10,180 | 10 | PFIZER INC. ($4,370) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $2,740.00 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $685.00 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $685.00 | General |
| Category: ONCOLOGY | ||||||
| 05/08/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $1,370.00 | General |
| Category: ONCOLOGY | ||||||
| 05/01/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $2,055.00 | General |
| Category: ONCOLOGY | ||||||
| 02/22/2024 | AstraZeneca Pharmaceuticals LP | — | Grant | Cash or cash equivalent | $350.00 | General |
| 02/06/2024 | Genentech, Inc. | Herceptin (Biological), Perjeta, Tecentriq | Food and Beverage | In-kind items and services | $81.67 | General |
| Category: BioOncology | ||||||
| 12/06/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,712.50 | General |
| 08/23/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $856.25 | General |
| Category: ONCOLOGY | ||||||
| 02/22/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $1,370.00 | General |
| Category: ONCOLOGY | ||||||
| 02/08/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $2,055.00 | General |
| Category: ONCOLOGY | ||||||
| 02/01/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $1,027.50 | General |
| Category: ONCOLOGY | ||||||
| 12/21/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| Category: ONCOLOGY | ||||||
| 12/21/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Travel and Lodging | In-kind items and services | $35.64 | General |
| Category: ONC | ||||||
| 12/16/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Travel and Lodging | In-kind items and services | $16.94 | General |
| Category: ONC | ||||||
| 12/09/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Consulting Fee | Cash or cash equivalent | $5,020.00 | General |
| Category: ONC | ||||||
| 11/04/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Travel and Lodging | In-kind items and services | $488.60 | General |
| Category: ONC | ||||||
| 11/04/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Travel and Lodging | In-kind items and services | $274.28 | General |
| Category: ONC | ||||||
| 11/04/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $43.10 | General |
| Category: ONC | ||||||
| 11/04/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $36.52 | General |
| Category: ONC | ||||||
| 11/04/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $36.52 | General |
| Category: ONC | ||||||
| 11/01/2022 | Genentech, Inc. | Herceptin (Biological), Perjeta, TECENTRIQ | Food and Beverage | In-kind items and services | $83.00 | General |
| Category: BioOncology | ||||||
| 09/02/2022 | GE HealthCare | — | Consulting Fee | Cash or cash equivalent | $3,738.00 | General |
| 08/16/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Consulting Fee | Cash or cash equivalent | $2,055.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 1 | 23 | 25 | $5,000 | $1,275 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 23 | 25 | $5,000 | $1,275 | 25.5% |
About Dr. Lori Goldstein, M.D
Dr. Lori Goldstein, M.D is a Specialist healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598735219.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lori Goldstein, M.D has received a total of $172,547 in payments from pharmaceutical and medical device companies, with $7,967 received in 2024. These payments were reported across 135 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($137,915).
As a Medicare-enrolled provider, Goldstein has provided services to 23 Medicare beneficiaries, totaling 25 services with total Medicare billing of $1,275. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Medical Oncology
- Location Philadelphia, PA
- Active Since 01/25/2006
- Last Updated 04/09/2018
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1598735219
Products in Payments
- Enhertu (Drug) $37,033
- ENHERTU (Drug) $16,283
- Ogivri (Biological) $15,288
- Non-Covered Product (Drug) $9,331
- Trodelvy (Drug) $5,952
- Halaven (Drug) $5,915
- TRODELVY (Drug) $5,638
- TECENTRIQ (Biological) $5,099
- Herceptin (Biological) $4,271
- XGEVA (Biological) $3,631
- PROSIGNA ASSAY (Device) $2,602
- LYNPARZA (Drug) $2,398
- Kadcyla (Biological) $1,943
- IBRANCE (Drug) $1,427
- KEYTRUDA (Biological) $470.50
- ZEJULA (Drug) $115.60
- Perjeta (Biological) $97.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Philadelphia
Hossein Borghaei, M.d, M.D
Specialist — Payments: $673,498
Dr. Phillip Ginsberg, D.o, D.O
Specialist — Payments: $135,934
Dr. Michael Metro, M.d, M.D
Specialist — Payments: $125,377
Dr. Russell Schilder, M.d, M.D
Specialist — Payments: $124,479
Dr. Daniel Pryma, Md, MD
Specialist — Payments: $83,465
Richard Bleicher, Md, MD
Specialist — Payments: $53,374